乳腺癌内乳前哨淋巴结活检核素示踪技术优化研究

段宝伟; 赵娜; 毕钊; 邱鹏飞; 许兴和; 陈玉光; 樊庆达; 王永胜

doi:10.19401/j.cnki.1007-3639.2023.02.006

您当前的位置：

首页 >

文章列表页 >

乳腺癌内乳前哨淋巴结活检核素示踪技术优化研究

专题论著 | 更新时间：2025-12-31

- 乳腺癌内乳前哨淋巴结活检核素示踪技术优化研究
- Radiotracer technique optimization for breast cancer internal mammary sentinel lymph node biopsy
- 中国癌症杂志 2023年33卷第2期页码：134-141
- 作者机构：
  
  1. 山东第一医科大学（山东省医学科学院）研究生部，山东济南 250118
  2. 山东省肿瘤防治研究院（山东省肿瘤医院）乳腺病中心，山东第一医科大学（山东省医学科学院），山东济南 250117
  3. 泰安市肿瘤防治院乳腺外科，山东泰安 271000
  4. 泰安市妇幼保健院儿科，山东泰安 271000
- 作者简介：
  
  [ "段宝伟（ORCID: 0000-0002-9322-6097），山东第一医科大学硕士研究生。" ]
  [ "王永胜，二级教授、博士研究生导师，山东省肿瘤医院乳腺病中心主任。现任中国抗癌协会乳腺癌专业委员会副主任委员，中国抗癌协会国际医疗交流分会副主任委员，中国临床肿瘤学会乳腺癌专家委员会常务委员，中国医师协会肿瘤分会乳腺癌学组副组长，中华医学会肿瘤学分会乳腺癌学组委员，国家卫健委乳腺癌诊疗规范专家组成员，全球乳腺癌大会国际指导专家委员会成员，山东省抗癌协会靶向治疗分会主任委员。于国内率先开展乳腺癌保留乳房手术、前哨淋巴结活检替代腋窝淋巴结清扫术、乳腺病变微创诊断等研究，作为组长单位和首席专家，牵头开展了中国临床早期乳腺癌前哨淋巴结活检替代腋窝清扫术的多中心研究、乳腺癌内乳区前哨淋巴结活检术的多中心前瞻性临床验证研究和新型示踪技术引导乳腺癌内乳前哨淋巴结活检的多中心前瞻性临床研究，研究成果已达到国际领先水平，并参与多项国际和国内乳腺癌Ⅲ期临床研究。以第一作者或通信作者发表论文200余篇，其中在SCI收录期刊上发表论文60余篇，出版专著（译著等）共4部，授权国家发明专利2项，获奖成果共5项，其中国家级1项、部（省）级4项，作为主要负责人承担国家级项目4项、部（省）级项目3项。" ]
- 基金信息：
  
  国家自然科学基金(81672638);山东省自然科学基金(ZR2021QH002)
- DOI：10.19401/j.cnki.1007-3639.2023.02.006
  中图分类号： R737.9
- 收稿：2022-11-15，
  
  修回：2023-02-08，
  
  纸质出版：2023-02-28
- 稿件说明：
移动端阅览
段宝伟, 赵娜, 毕钊, 等. 乳腺癌内乳前哨淋巴结活检核素示踪技术优化研究[J]. 中国癌症杂志, 2023,33(2):134-141.

Baowei DUAN, Na ZHAO, Zhao BI, et al. Radiotracer technique optimization for breast cancer internal mammary sentinel lymph node biopsy[J]. China Oncology, 2023, 33(2): 134-141.
段宝伟, 赵娜, 毕钊, 等. 乳腺癌内乳前哨淋巴结活检核素示踪技术优化研究[J]. 中国癌症杂志, 2023,33(2):134-141. DOI： 10.19401/j.cnki.1007-3639.2023.02.006.

Baowei DUAN, Na ZHAO, Zhao BI, et al. Radiotracer technique optimization for breast cancer internal mammary sentinel lymph node biopsy[J]. China Oncology, 2023, 33(2): 134-141. DOI： 10.19401/j.cnki.1007-3639.2023.02.006.

摘要

背景与目的：

山东省肿瘤防治研究院（山东省肿瘤医院）乳腺病中心前期研发新型核素示踪技术，显著提高了内乳前哨淋巴结（internal mammary sentinel lymph node，IMSLN）显像率，但该技术获得的IMSLN显像率相较于腋窝前哨淋巴结（axillary sentinel lymph node，ASLN）仍然存在一定差距。本研究旨在通过优化新型核素示踪技术，进一步提高IMSLN显像率，推动内乳前哨淋巴结活检（internal mammary sentinel lymph node biopsy，IM-SLNB）广泛应用。

方法：

前瞻性入组159例原发性乳腺癌患者，分为优化核素示踪技术组（

= 81，A组）和新型核素示踪技术组（

= 78，B组）。A组在超声引导下将

99m

Tc-硫胶体平均注射在腺体最丰富的3个区域腺体实质内（总放射强度1.0 ~ 1.3 mCi；0.8 ~ 1.0 mL/点）。B组在超声引导下将

99m

Tc-硫胶体平均注射在乳腺6点和12点腺体实质内（总放射强度1.0 ~ 1.3 mCi；0.8 ~ 1.0 mL/点）。术前进行单光子发射计算机断层扫描（single photon emission computed tomography，SPECT）/计算机体层成像（computed tomography，CT）淋巴显像，术中γ探测仪探测前哨淋巴结。比较两组患者IMSLN及ASLN显像率的差异，同时分析可能影响IMSLN显像率的因素。

结果：

术前SPECT/CT IMSLN显像率在两组间差异无统计学意义（

= 0.806）。术中IMSLN显像率A组显著高于B组（87.65%

70.51%，

= 0.008）。亚组分析显示，A组年龄≤50岁和

50岁患者术中IMSLN显像率分别为92.31% 和 83.33%（

= 0.315），B组年龄≤50岁患者术中IMSLN显像率显著高于

50岁患者（81.58%

60.00%，

= 0.037）。A组IMSLN的中位体外放射性计数显著高于B组（160.50

59.00，

= 0.005）。

结论：

优化核素示踪技术能有效地增加核素内乳区淋巴引流及摄取，可在不影响ASLN显像率的同时显著提高IMSLN显像率，有利于IM-SLNB推广应用。

Abstract

Background and purpose:

The modified injection technique developed in Shandong Cancer Hospital and Institute

Shandong First Medical University and Shandong Academy of Medical Sciences has significantly improved the visualization rate of internal mammary sentinel lymph nodes (IMSLN)

however there is still a gap between the visualization rate of IMSLN obtained by this technique and that of axillary sentinel lymph nodes (ASLN). The study aimed to further improve the IMSLN visualization rate and promote the widespread use of internal mammary sentinel lymph node biopsy (IM-SLNB) by optimizing the modified injection technique.

Methods:

A total of 159 patients with primary breast cancer were enrolled in a prospective group and divided into the optimized radiotracer technique group (group A

=81) and the modified injection technique group (group B

=78). In group A

99m

Tc-sulfur colloid was injected averagely into parenchyma in the gland's three most abundant regions under ultrasound guidance (total radioactive intensity 1.0-1.3 mCi; 0.8-1.0 mL/point). In group B

99mTc-sulfur colloid was injected averagely into the parenchyma of the breast at 6 and 12 points under ultrasound guidance (total radioactive intensity 1.0-1.3 mCi; 0.8-1.0 mL/point). Single photon emission computed tomography (SPECT)/computed tomography (CT) lymphoscintigraphy was performed preoperatively

and the sentinel lymph nodes were detected intraoperatively by γ probe. In this study

we evaluated the differences in IMSLN and ASLN visualization rates between the groups

and also analyzed the factors that may affect the IMSLN visualization rate.

Results:

There was no statistically significant difference in visualization rate of IM-SLN measured by preoperative SPECT/CT between the two groups (

=0.806). The intraoperative visualization rate of IM-SLN was significantly higher in group A than in group B (87.65%

70.51%

=0.008). Analysis of

subgroups showed that the intraoperative visualization rate of IMSLN was 92.31% and 83.33% (

=0.315) in group A patients aged ≤50 years and

50 years

respectively

and the intraoperative visualization rate of IMSLN was significantly higher in group B patients aged ≤50 years than in patients aged

50 years (81.58%

60.00%

=0.037). The median in vitro radioactivity count of IMSLN was significantly higher in group A than in group B (160.50

59.00

=0.005).

Conclusion:

The optimized radiotracer technique can effectively increase the lymphatic drainage and uptake in the internal mammary region of the radiotracer

which can significantly improve the visualization rate of IM-SLN without affecting the visualization rate of ASLN

and is conducive to the promotion and application of IM-SLNB.

关键词

Keywords

references

HULTBORN K A , LARSSON L G , RAGNHULT I . The lymph drainage from the breast to the axillary and parasternal lymph nodes, studied with the aid of colloidal Au198 [J ] . Acta radiol , 1955 , 43 ( 1 ): 52 - 64 . DOI: 10.3109/00016925509172744 http://doi.org/10.3109/00016925509172744

KRAG D N , ANDERSON S J , JULIAN T B , et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial [J ] . Lancet Oncol , 2010 , 11 ( 10 ): 927 - 933 . DOI: 10.1016/S1470-2045(10)70207-2 http://doi.org/10.1016/S1470-2045(10)70207-2

GIULIANO A E , BALLMAN K , MCCALL L , et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons oncology group (alliance) ACOSOG Z0011 randomized trial [J ] . Ann Surg , 2016 , 264 ( 3 ): 413 - 420 . DOI: 10.1097/SLA.0000000000001863 http://doi.org/10.1097/SLA.0000000000001863

GIULIANO A E , BALLMAN K V , MCCALL L , et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial [J ] . JAMA , 2017 , 318 ( 10 ): 918 - 926 . DOI: 10.1001/jama.2017.11470 http://doi.org/10.1001/jama.2017.11470 http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2017.11470 http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2017.11470

WETZIG N , GILL P G , ESPINOZA D , et al. Sentinel-lymph-node-based management or routine axillary clearance? Five-year outcomes of the RACS sentinel node biopsy versus axillary clearance (SNAC) 1 trial: assessment and incidence of true lymphedema [J ] . Ann Surg Oncol , 2017 , 24 ( 4 ): 1064 - 1070 . DOI: 10.1245/s10434-016-5669-2 http://doi.org/10.1245/s10434-016-5669-2

GALIMBERTI V , COLE B F , VIALE G , et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial [J ] . Lancet Oncol , 2018 , 19 ( 10 ): 1385 - 1393 . DOI: S1470-2045(18)30380-2 http://doi.org/S1470-2045(18)30380-2

ASADI M , KRAG D . Internal mammary sentinel lymph node biopsy in clinical practice [J ] . Int J Surg , 2016 , 36 (Pt A): 332 - 334 . DOI: S1743-9191(16)31043-3 http://doi.org/S1743-9191(16)31043-3

BI Z , CHEN P , LIU J J , et al. Internal mammary sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer [J ] . J Breast Cancer , 2018 , 21 ( 4 ): 442 - 446 . DOI: 10.4048/jbc.2018.21.e49 http://doi.org/10.4048/jbc.2018.21.e49

QIU P F , ZHAO R R , WANG W , et al. Internal mammary sentinel lymph node biopsy in clinically axillary lymph node-positive breast cancer: diagnosis and implications for patient management [J ] . Ann Surg Oncol , 2020 , 27 ( 2 ): 375 - 383 . DOI: 10.1245/s10434-019-07705-0 http://doi.org/10.1245/s10434-019-07705-0

SHIMAZU K , TAMAKI Y , TAGUCHI T , et al. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer [J ] . Ann Surg , 2003 , 237 ( 3 ): 390 - 398 .

RODIER J F , VELTEN M , WILT M , et al. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial [J ] . J Clin Oncol , 2007 , 25 ( 24 ): 3664 - 3669 . DOI: 10.1200/JCO.2006.08.4228 http://doi.org/10.1200/JCO.2006.08.4228 https://ascopubs.org/doi/10.1200/JCO.2006.08.4228 https://ascopubs.org/doi/10.1200/JCO.2006.08.4228

MUDUN A , SANLI Y , OZMEN V , et al. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience [J ] . Clin Nucl Med , 2008 , 33 ( 4 ): 262 - 267 . DOI: 10.1097/RLU.0b013e3181662fc7 http://doi.org/10.1097/RLU.0b013e3181662fc7

QIU P F , CONG B B , ZHAO R R , et al. Internal mammary sentinel lymph node biopsy with modified injection technique: high visualization rate and accurate staging [J ] . Medicine (Baltimore) , 2015 , 94 ( 41 ): e1790 . DOI: 10.1097/MD.0000000000001790 http://doi.org/10.1097/MD.0000000000001790 https://journals.lww.com/00005792-201510020-00034 https://journals.lww.com/00005792-201510020-00034

QIU P F , WANG X E , WANG Y S . Indications for individual internal mammary node irradiation [J ] . Lancet Oncol , 2021 , 22 ( 2 ): e40 . DOI: 10.1016/S1470-2045(20)30739-7 http://doi.org/10.1016/S1470-2045(20)30739-7 https://linkinghub.elsevier.com/retrieve/pii/S1470204520307397 https://linkinghub.elsevier.com/retrieve/pii/S1470204520307397

王永胜 , 赵荣荣 , 刘雁冰 , 等 . 精准医学时代乳腺癌内乳前哨淋巴结活检适应证的探讨 [J ] . 中华肿瘤杂志 , 2019 , 41 ( 4 ): 251 - 256 .

WANG Y S , ZHAO R R , LIU Y B , et al. Discussion on the indications of internal mammary sentinel lymph node biopsy in breast cancer in the era of precision medicine [J ] . Chin J Oncol , 2019 , 41 ( 4 ): 251 - 256 .

毕钊 , 刘静静 , 陈鹏 , 等 . 乳腺癌新辅助化疗后内乳区前哨淋巴结活检研究 [J ] . 中国癌症杂志 , 2019 , 29 ( 2 ): 131 - 135 . DOI: 10.19401/j.cnki.1007-3639.2019.02.006 http://doi.org/10.19401/j.cnki.1007-3639.2019.02.006

BI Z , LIU J J , CHEN P , et al. Internal mammary sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy [J ] . China Oncol , 2019 , 29 ( 2 ): 131 - 135 .

TANIS P J , NIEWEG O E , VALDÉS OLMOS R A , et al. Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy [J ] . J Am Coll Surg , 2001 , 192 ( 3 ): 399 - 409 . DOI: 10.1016/S1072-7515(00)00776-6 http://doi.org/10.1016/S1072-7515(00)00776-6 https://journals.lww.com/00019464-200103000-00016 https://journals.lww.com/00019464-200103000-00016

YU J M , LI G , LI J B , et al. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields [J ] . Int J Radiat Oncol Biol Phys , 2005 , 61 ( 3 ): 874 - 878 . DOI: 10.1016/j.ijrobp.2004.06.252 http://doi.org/10.1016/j.ijrobp.2004.06.252 https://linkinghub.elsevier.com/retrieve/pii/S0360301604019923 https://linkinghub.elsevier.com/retrieve/pii/S0360301604019923

BRESLIN J W , YANG Y , SCALLAN J P , et al. Lymphatic vessel network structure and physiology [J ] . Compr Physiol , 2018 , 9 ( 1 ): 207 - 299 . DOI: 10.1002/cphy.c180015 http://doi.org/10.1002/cphy.c180015

浏览量

2289

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

乳腺癌内乳前哨淋巴结活检与患者预后的相关性研究

乳腺癌前哨淋巴结阳性豁免腋窝清扫后区域淋巴结放疗的回顾性研究

早期乳腺癌局部治疗与全身治疗的进展与展望

临床查体阴性但超声检查及穿刺确诊腋窝淋巴结转移的乳腺癌前哨淋巴结活检的可行性分析

乳腺癌患者保乳手术后再次前哨淋巴结活检的最新研究进展及展望